Quarterly report pursuant to Section 13 or 15(d)

Schedule of Supplemental Disclosure of Cash Flow Information (Details)

v3.21.2
Schedule of Supplemental Disclosure of Cash Flow Information (Details) - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dividends Payable [Line Items]    
Cash paid for interest $ 9,455
Cash paid for income taxes 281,025
Preferred stock of VisualMED received from the sale of HTS and AMSG 8,500,000
Net liabilities of HTS and AMSG transferred to VisualMED 2,227,152
Series I-2 Preferred Stock converted into common stock 25,000
Exchange of Series K Preferred Stock for Series L Preferred Stock (2,500)
Issuance of Series L Preferred Stock 2,500
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest 22,000,000
Loans and accrued interest exchanged for Series M Preferred Stock 18,849,632
Deemed dividend from exchange of loans and accrued interest for Series M Preferred Stock 3,150,368
Deemed dividends for trigger of down round provisions 149,611,479
Original issue discounts on debt 27,630 63,695
Series M Preferred Stock [Member]    
Dividends Payable [Line Items]    
Series N Preferred Stock converted into common stock 619,650
Series N Preferred Stock [Member]    
Dividends Payable [Line Items]    
Series N Preferred Stock converted into common stock $ 13,065,527